Take-home naloxone: research dispels concern that it increases drug-related risk behaviour

September 2023
Dr Samantha Colledge-Frisby examines the perception that people may engage in risk compensation when they have naloxone at hand.
Read more
April 2019

Why focusing on the AOD workforce is important

Dr Natalie Skinner, Senior Research Fellow, NCETA
February 2019

How is Australia responding to the pharmaceutical opioid problem?

Dr Gabrielle Campbell, NHMRC Australian Public Health Early Career Fellow at NDARC, UNSW.
December 2018

Cannabis regulation: Profit versus public health

Professor Simon Lenton, Director, NDRI
October 2018

Clinical practice guidelines: Questions of relevance, reliability and utility explored

Professor Ann Roche, Director, NCETA
August 2018

Can we improve processes for engaging communities and services in research?

Professor Anthony Shakeshaft, National Drug and Alcohol Research Centre, UNSW Sydney
June 2018

Renewed interest in psychedelics as potentially useful therapeutic agents

NDRI Adjunct Research Fellow Dr Stephen Bright shares his views about psychedelic research programs that have been initiated by several prestigious in
May 2018

Wastewater analysis - what does it mean for AOD policy and practice?

Ann Roche, Director & Allan Trifonoff, Deputy Director (Programs), NCETA
March 2018

To reduce child injury deaths in Australia we need to look at the link to adult alcohol consumption

Dr Anne-Marie Laslett, Senior Research Fellow, NDRI
December 2017

Health economics is not just about measuring costs

Dr Marian Shanahan, NDARC
October 2017

Drug testing: How it works and what it can, and cannot, achieve

Associate Professor Ken Pidd, Deputy Director (Research), NCETA

Pages